![](https://endpts.com/wp-content/uploads/2023/03/Abraham-Ceesay-Rapport-tile.jpg)
Abraham Ceesay, Rapport Therapeutics CEO
Neuroscience company Rapport Therapeutics lists on Nasdaq
Rapport Therapeutics expects to raise $154 million from its initial public offering and a concurrent stock sale to private investors, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.